Published in Int J Epidemiol on December 01, 1993
Awareness, treatment, and control of hypertension in Canada. Am J Hypertens (1997) 4.76
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet (1996) 3.56
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet (2000) 3.50
Oesophageal cancer studies in the Caspian Littoral of Iran: the Caspian cancer registry. Br J Cancer (1973) 2.93
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet (1999) 2.36
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. J Natl Cancer Inst (1998) 2.33
Cancer of the breast: a study of 1520 consecutive patients operated on between 1960 and 1980. Can J Surg (1991) 2.06
Factors determining compliance with screening mammography. CMAJ (1996) 1.97
Influences on diet, health behaviours and their outcome in select ethnocultural and religious groups. Nutrition (1998) 1.90
Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet (1998) 1.88
Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet (2001) 1.87
Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus. Sex Transm Dis (1997) 1.71
Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst (1997) 1.68
Ingested mutagens from opium and tobacco pyrolysis products and cancer of the oesophagus. Lancet (1978) 1.59
Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer (2011) 1.51
The role of genetic factors in the etiology of pancreatic adenocarcinoma: an update. Cancer Invest (2001) 1.51
Rapid progression of prostate cancer in men with a BRCA2 mutation. Br J Cancer (2008) 1.45
Is there a correlation between the structure of hair and breast cancer or BRCA1/2 mutations? Phys Med Biol (2002) 1.41
Survival of breast-cancer patients with previous or subsequent neoplasms. Can J Surg (1992) 1.39
Nutrition factors in relation to cellular and regulatory immune variables in a free-living elderly population. Am J Clin Nutr (1990) 1.39
Oesophageal cancer studies in the Caspian littoral of Iran: some residual results, including opium use as a risk factor. Int J Cancer (1985) 1.38
Plant foods, antioxidants, and prostate cancer risk: findings from case-control studies in Canada. Nutr Cancer (1999) 1.36
Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol (2011) 1.36
A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer. J Med Genet (2002) 1.35
Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2012) 1.35
Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators. Am J Hum Genet (1998) 1.35
Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2004) 1.34
The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer (2012) 1.34
Familial pancreatic cancer: a review. Semin Oncol (1996) 1.30
Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2011) 1.29
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics (2001) 1.23
Cigarette smoking and pancreas cancer: a case control study of the search programme of the IARC. Int J Cancer (1996) 1.21
Mutagens produced by the pyrolysis of opium and its alkaloids as possible risk factors in cancer of the bladder and oesophagus. Carcinogenesis (1982) 1.21
Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol (1992) 1.21
Nutritional factors and pancreatic cancer in the francophone community in Montréal, Canada. Int J Cancer (1991) 1.20
A collaborative case-control study of nutrient intake and pancreatic cancer within the search programme. Int J Cancer (1992) 1.17
Psychosocial and lifestyle factors associated with insufficient and excessive maternal weight gain during pregnancy. J Am Diet Assoc (2000) 1.12
Perception of cancer detection and early treatment in a population participating in the National Breast Screening Study in Canada. Can J Public Health (1989) 1.12
Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2011) 1.10
Tobacco, alcohol, and coffee and cancer of the pancreas. A population-based, case-control study in Quebec, Canada. Cancer (1991) 1.09
A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes. Clin Genet (2000) 1.07
Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians. Breast Cancer Res Treat (2006) 1.05
Shanghai trial of nifedipine in the elderly (STONE). J Hypertens (1996) 1.04
Food habits and pancreatic cancer: a case-control study of the Francophone community in Montreal, Canada. Cancer Epidemiol Biomarkers Prev (1995) 1.04
Specific fatty acid intake and the risk of pancreatic cancer in Canada. Br J Cancer (2005) 1.04
Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control study. Am J Obstet Gynecol (1998) 1.01
Alcohol and other beverage use and prostate cancer risk among Canadian men. Int J Cancer (1998) 1.00
Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions. Int J Cancer (2001) 0.99
A large multisite cancer family is linked to BRCA2. J Med Genet (1995) 0.98
Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma. Oncogene (2007) 0.96
Dental amalgam and multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol (1998) 0.95
The reliability of recollections of family history: implications for the medical provider. J Cancer Educ (1997) 0.95
Hereditary breast cancer in 19 females and 2 males: Kindred, P.G. 1940. Eur J Cancer (1995) 0.94
No association between P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck. Br J Cancer (2000) 0.94
DNA synthesis and neoplastic transformation in rat liver parenchyma. Cancer Res (1966) 0.93
[Diabetes mellitus and pancreatic cancer: a case-control study in greater Montreal, Quebec, Canada]. Rev Epidemiol Sante Publique (1992) 0.93
Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent. Clin Genet (2006) 0.92
Obesity, hypertension, hyperuricemia and diabetes mellitus among the Cree and Inuit of northern Québec. Arctic Med Res (1990) 0.92
Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer families. Hum Hered (2001) 0.91
The National Breast Screening Study: pre-recruitment sources of awareness in participants. Can J Public Health (1989) 0.91
A population-based case-control study of cancer of the bile ducts and gallbladder in Quebec, Canada. Rev Epidemiol Sante Publique (1993) 0.90
Tracer oxygen distribution is barrier-limited in the cerebral microcirculation. Circ Res (1995) 0.89
Specific fatty acids and human colorectal cancer: an overview. Cancer Detect Prev (2003) 0.88
Accuracy of reports of familial breast cancer in a case-control series. Epidemiology (1995) 0.88
Specific inhibition of the incorporation of tritiated thymidine in regenerating rat liver by a rat hepatocytes supernatant. Rev Can Biol (1977) 0.87
Diet quality and BRCA-associated breast cancer risk. Breast Cancer Res Treat (2006) 0.87
Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history. Clin Genet (1999) 0.87
Effects of flow, perfusion pressure, and oxygen consumption on cardiac capillary exchange. J Appl Physiol (1985) (1995) 0.87
Nutrient patterns and nutritional adequacy among French-Canadian children in Montreal. J Am Coll Nutr (1996) 0.86
Cancer of the pancreas in two brothers and one sister. Int J Pancreatol (1988) 0.86
Early detection of esophageal squamous cell carcinoma and its effects on therapy: an overview. Dis Esophagus (1999) 0.85
Variations in the cell cycle during azo dye hepatocarcinogenesis. J Natl Cancer Inst (1968) 0.85
[Quality of life of patients after restorative surgery for cancer of the rectum]. Ann Chir (1992) 0.84
Founder BRCA1 and BRCA2 mutations in early-onset French Canadian breast cancer cases unselected for family history. Int J Cancer (2001) 0.84
Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer. Clin Genet (2001) 0.83
Surface morphology and nucleoside phosphatase activity of rat liver epithelial cells during oncogenic transformation in vitro. Cancer Res (1977) 0.83
Inhibition of cell proliferation in the livers of hepatectomized rats by a rabbit hepatic chalone. Proc Natl Acad Sci U S A (1974) 0.83
Biochemical indices of nutritional status in maternal, cord, and early neonatal blood. Am J Clin Nutr (1982) 0.83
Familial clustering of obesity and breast cancer. Genet Epidemiol (1996) 0.83
[Breast cancer screening: is family medicine intervention effective?]. Union Med Can (1994) 0.83
[Geographical relations between mortality from cancer of the esophagus, cirrhosis of the liver, alcohol and tobacco: case of the Province of Quebec]. Soc Sci Med (1986) 0.83
Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation. Clin Genet (2008) 0.83
Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma. Br J Cancer (2000) 0.83
Continuous ambulatory peritoneal dialysis for patients with severe left ventricular systolic dysfunction and end-stage renal disease. Am J Kidney Dis (1995) 0.82
Natural history of Epstein-Barr virus infection in a prospective pediatric cohort born to human immunodeficiency virus-infected mothers. J Infect Dis (1998) 0.82
Familial history of esophageal cancer. Cancer (1985) 0.82
Re: Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. J Natl Cancer Inst (2001) 0.81
Familial cancer of the esophagus in Iran. Cancer (1974) 0.81
Nutrient intake and esophageal cancer in the Caspian littoral of Iran: a case-control study. Cancer Detect Prev (2000) 0.81
Vitamin D deficiency and cancer of the breast: an unprovocative ecological hypothesis. Can J Public Health (1992) 0.81
Human immunodeficiency virus infection is a major risk factor for detection of human papillomavirus DNA in esophageal brushings. Clin Infect Dis (1997) 0.81
Antibody responses to two Epstein-Barr virus (EBV) nuclear antigens (EBNA-1 and EBNA-2) during EBV primary infection in children born to mothers infected with human immunodeficiency virus. Clin Infect Dis (1996) 0.81
Sulfation of acetaminophen by the perfused rat liver: the effect of red blood cell carriage. Hepatology (1995) 0.80
Disappearance of nitrite from the rat stomach: contribution of emptying and other factors. J Natl Cancer Inst (1975) 0.80
Hepatic uptake and metabolism of benzoate: a multiple indicator dilution, perfused rat liver study. Am J Physiol Gastrointest Liver Physiol (2001) 0.79